Aspire BioPharma Inc. (ASBP)

NASDAQ: ASBP · Real-Time Price · USD

0.37

-0.05 (-12.74%)

At close: May 01, 2025, 3:59 PM

0.38

3.29%

After-hours: May 01, 2025, 07:51 PM EDT

Aspire BioPharma Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	-1.31M	-359.07K	-597.12K
Depreciation & Amortization	n/a	n/a	n/a
Stock-Based Compensation	n/a	n/a	n/a
Other Working Capital	1.04M	396.07K	-48.52K
Other Non-Cash Items	n/a	-1	n/a
Deferred Income Tax	n/a	n/a	n/a
Change in Working Capital	1.04M	446.11K	454.21K
Operating Cash Flow	-265.19K	87.04K	-142.91K
Capital Expenditures	n/a	-75.9K	-4.9M
Cash Acquisitions	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	-4.9M
Debt Repayment	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a
Other Financial Acitivies	-11.98M	n/a	3.85M
Financial Cash Flow	-11.73M	n/a	4.85M
Net Cash Flow	-7.54K	11.14K	-185.46K
Free Cash Flow	-265.19K	11.14K	-5.04M